English

IRADIMED CORPORATION

EDGAR

IRMD Current report (8-K) · filed 2026-10-30

Annual consolidated revenue for 2025: about Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 83.81M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 73.24M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

24.2 million USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 24203000 USD Source

Operating margin

33.63%

2026 Q3 · %

Exact inputs and evidence

Operating Income: 8139000 USD Source
Revenue: 24203000 USD Source

Operating cash flow

7 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 21227000 USD Source
Operating Cash Flow: 14230000 USD Source

Free cash flow

6.87 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 21227000 USD Source
Operating Cash Flow: 14230000 USD Source
Capital Expenditure: 718000 USD Source
Capital Expenditure: 588000 USD Source

Cash and cash equivalents: 63.3 million USD 2026-09-30 Source
Exact value

63288000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 12.8 million shares 2026-09-30 Source
Exact value

12788153 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2025-12-31
Operating income: 2 of 11 periods available· newest 2025-12-31
Net income: 2 of 11 periods available· newest 2025-12-31
Operating cash flow: 2 of 11 periods available· newest 2025-12-31
Capital expenditure: 2 of 11 periods available· newest 2025-12-31
Total assets: Multiple units; comparison withheld· newest 2025-12-31
Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
Current assets: Multiple units; comparison withheld· newest 2025-12-31
Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+14.4%

Prior period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 73.24 million

2024-01-01 – 2024-12-31
Current period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 83.81 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

83814000 − 73242000 = 10572000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg

73242000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
83814000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Year-over-year change in Revenue: 10572000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 83814000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1438309 Filing: 000110465926024691 Input fundies:Revenue: 73242000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1439403 Filing: 000110465926024691
The citation records this snapshot. The page link may show a newer release later.
Net income
+16.9%

Prior period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 19.23 million

2024-01-01 – 2024-12-31
Current period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 22.48 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

22480000 − 19234000 = 3246000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg

19234000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
22480000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Year-over-year change in Net income: 3246000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 22480000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1320842 Filing: 000110465926024691 Input fundies:NetIncome: 19234000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1321900 Filing: 000110465926024691
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-2.6%

Prior period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 25.62 million

2024-01-01 – 2024-12-31
Current period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 24.95 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

24947000 − 25624000 = -677000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg

25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Year-over-year change in Operating cash flow: -677000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1212926 Filing: 000110465926024691 Input fundies:OperatingCashFlow: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1214099 Filing: 000110465926024691
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-3%

Prior period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 8.01 million

2024-01-01 – 2024-12-31
Current period

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 7.77 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

7765000 − 8005000 = -240000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg

8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Year-over-year change in Capital expenditure: -240000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1218018 Filing: 000110465926024691 Input fundies:CapitalExpenditure: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1219043 Filing: 000110465926024691
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 83.81 million 100% of revenue
Cost of revenue Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 19.49 million 23% of revenue
Operating expenses Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 38.18 million 46% of revenue
Operating income Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 26.15 million 31% of revenue
Tax, interest and other Derived Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 3.67 million 4.4% of revenue
Net income Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 22.48 million 27% of revenue

Cash

Operating cash flow Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 24.95 million 30% of revenue
Capital expenditure Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 7.77 million 9.3% of revenue
Free cash flow Derived Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 17.18 million 21% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2024 26%70%
2025 27%69%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2024 2024-01-01 – 2024-12-31	73242000	51277000 Derived	21965000	2731000 Derived	19234000	17619000 Derived	Source 2024-01-01 – 2024-12-31: 73242000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Revenue Open source 2024-01-01 – 2024-12-31: 21965000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Operating Income Open source 2024-01-01 – 2024-12-31: 19234000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Net Income Open source 2024-01-01 – 2024-12-31: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	83814000	57667000 Derived	26147000	3667000 Derived	22480000	17182000 Derived	Source 2025-01-01 – 2025-12-31: 83814000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Revenue Open source 2025-01-01 – 2025-12-31: 26147000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 22480000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Net Income Open source 2025-01-01 – 2025-12-31: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Capital Expenditure Open source

Amounts are exact, in Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 83.8M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg)	Source evidence
20242024-12-31	Revenue	73242000	Revenue: 73242000 Open source
20252025-12-31	Revenue	83814000	Revenue: 83814000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

14.4% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20242024-12-31	Year over year	No prior comparable period	Revenue: 73242000 Open source
20252025-12-31	Year over year	14.4%	Revenue: 83814000 Open source Revenue: 73242000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 31.2% 2025

Net margin 26.8% 2025

Free cash flow margin 20.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20242024-12-31	Operating margin	30%	Operating Income: 21965000 Open source Revenue: 73242000 Open source
20252025-12-31	Operating margin	31.2%	Operating Income: 26147000 Open source Revenue: 83814000 Open source
20242024-12-31	Net margin	26.3%	Net Income: 19234000 Open source Revenue: 73242000 Open source
20252025-12-31	Net margin	26.8%	Net Income: 22480000 Open source Revenue: 83814000 Open source
20242024-12-31	Free cash flow margin	24.1%	Revenue: 73242000 Open source Operating Cash Flow: 25624000 Open source Capital Expenditure: 8005000 Open source
20252025-12-31	Free cash flow margin	20.5%	Revenue: 83814000 Open source Operating Cash Flow: 24947000 Open source Capital Expenditure: 7765000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 24.9M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg)	Source evidence
20242024-12-31	Operating cash flow	25624000	Operating Cash Flow: 25624000 Open source
20252025-12-31	Operating cash flow	24947000	Operating Cash Flow: 24947000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 17.2M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg)	Source evidence
20242024-12-31	Free cash flow	17619000	Operating Cash Flow: 25624000 Open source Capital Expenditure: 8005000 Open source
20252025-12-31	Free cash flow	17182000	Operating Cash Flow: 24947000 Open source Capital Expenditure: 7765000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2024-12-31	Liabilities / assets	Not reported	No source recorded
2025-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2024-12-31	Current assets / current liabilities	Not reported	No source recorded
2025-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2024 2024-01-01 – 2024-12-31	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 19.23 million Exact value Exact value: 19234000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2024-01-01 – 2024-12-31: 19234000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Net Income Open source Share or cite Citation for Net Income · IRADIMED CORPORATION · 2024-12-31 IRADIMED CORPORATION (edgar:1325618) Net Income: 19234000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg&dimensions= Input fundies:NetIncome: 19234000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1321900 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 25.62 million Exact value Exact value: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2024-01-01 – 2024-12-31: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IRADIMED CORPORATION · 2024-12-31 IRADIMED CORPORATION (edgar:1325618) Operating Cash Flow: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg&dimensions= Input fundies:OperatingCashFlow: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1214099 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 8.01 million Exact value Exact value: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2024-01-01 – 2024-12-31: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IRADIMED CORPORATION · 2024-12-31 IRADIMED CORPORATION (edgar:1325618) Capital Expenditure: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg&dimensions= Input fundies:CapitalExpenditure: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1219043 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 17.62 million Calculation and evidence 25624000 − 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Exact free cash flow: 17619000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2024-01-01 – 2024-12-31: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IRADIMED CORPORATION · 2024-12-31 IRADIMED CORPORATION (edgar:1325618) Free cash flow: 17619000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25624000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1214099 Filing: 000110465926024691 Input fundies:CapitalExpenditure: 8005000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1219043 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 22.48 million Exact value Exact value: 22480000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2025-01-01 – 2025-12-31: 22480000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Net Income Open source Share or cite Citation for Net Income · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Net Income: 22480000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg&dimensions= Input fundies:NetIncome: 22480000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1320842 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 24.95 million Exact value Exact value: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2025-01-01 – 2025-12-31: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Operating Cash Flow: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg&dimensions= Input fundies:OperatingCashFlow: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1212926 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 7.77 million Exact value Exact value: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2025-01-01 – 2025-12-31: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Capital Expenditure: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg&dimensions= Input fundies:CapitalExpenditure: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1218018 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.	Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 17.18 million Calculation and evidence 24947000 − 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Exact free cash flow: 17182000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg 2025-01-01 – 2025-12-31: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IRADIMED CORPORATION · 2025-12-31 IRADIMED CORPORATION (edgar:1325618) Free cash flow: 17182000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1325618?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24947000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1212926 Filing: 000110465926024691 Input fundies:CapitalExpenditure: 7765000 Unit_Standard_USD_IxNEITNiKEGoeGIFMtxGKg (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm#1218018 Filing: 000110465926024691 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

201 filings · 6,568 latest values · 6,568 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001325618, 1325618, IRMD, edgar:1325618

Also known as IRADIMED CORP, IRADIMED CORPORATION

IRADIMED CORPORATION

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation